Cited by 630Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial

Open access

Dysken, Maurice W., Sano, Mary, Asthana, Sanjay, Vertrees, Julia E., Pallaki, Muralidhar, Llorente, Maria, Love, Susan, Schellenberg, Gerard D., McCarten, J. Riley, Malphurs, Julie, Prieto, Susana, Chen, Peijun, Loreck, David J., Trapp, George, Bakshi, Rajbir S., Mintzer, Jacobo E., Heidebrink, Judith L., Vidal-Cardona, Ana, Arroyo, Lillian M., Cruz, Angel R., Zachariah, Sally, Kowall, Neil W., Chopra, Mohit P., Craft, Suzanne, Thielke, Stephen, Turvey, Carolyn L., Woodman, Catherine, Monnell, Kimberly A., Gordon, Kimberly, Tomaska, Julie, Segal, Yoav, Peduzzi, Peter N., Guarino, Peter D.·2014·JAMA

DOI 10.1001/jama.2013.282834PMC PMC4109898

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE: To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS: Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES: Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS: Data from 561 participants were analyzed (alpha tocopherol = 140, memantine = 142, combination = 139, placebo = 140), with 52 excluded because of a lack of any follow-up data. Over the mean (SD) follow-up of 2.27 (1.22) years, ADCS-ADL Inventory scores declined by 3.15 units (95% CI, 0.92 to 5.39; adjusted P = .03) less in the alpha tocopherol group compared with the placebo group. In the memantine group, these scores declined 1.98 units less (95% CI, -0.24 to 4.20; adjusted P = .40) than the placebo group's decline. This change in the alpha tocopherol group translates into a delay in clinical progression of 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period. Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations," with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00235716.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2013.282834

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Self-citation
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043

Flagged first, then by citations

Show all 40 references

Sorted by citations

Items 101–200 of 630

Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease
Prasad, K. N. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.01.002 · Cited by 83
Regulation of gut microbiota by vitamin C, vitamin E and β-carotene
Li, X., Meng, L., Shen, L., & Ji, H. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112749 · Cited by 85
Redox changes and cellular senescence in Alzheimer's disease
Yu, N., Pasha, M., & Chua, J. J. E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103048 · Cited by 80
Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice
Chen, L., Dar, N. J., Na, R., McLane, K. D., Yoo, K., Han, X., & Ran, Q. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.002 · Cited by 80
Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer’s Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study
Remington, R., Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., & Shea, T. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151098 · Cited by 77
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease
Ashraf, A., & So, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00196 · Cited by 76
Memantine: Updating a rare success story in pro-cognitive therapeutics
Tari, P. K., Parsons, C. G., Collingridge, G. L., & Rammes, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109737 · Cited by 78
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Mayer, C., Riera‐Ponsati, L., Kauppinen, S., Klitgaard, H., Erler, J. T., & Hansen, S. N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1437939 · Cited by 80
Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75
Serum concentrations of vitamin E and carotenoids are altered in Alzheimer's disease: A case‐control study
Mullan, K., Williams, M. A., Cardwell, C. R., McGuinness, B., Passmore, P., Silvestri, G., Woodside, J. V., & McKay, G. J. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.06.006 · Cited by 79
Health-Promoting Strategies for the Aging Brain
Chen, S. T., Volle, D. C., Jalil, J., Wu, P., & Small, G. W. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.12.016 · Cited by 75
The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer’s disease phenotype
Joshi, Y. B., & Praticò, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00436 · Cited by 75
The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men.
Wahjoepramono, E. J., Asih, P. R., Aniwiyanti, V., Taddei, K., Dhaliwal, S. S., Fuller, S. J., Foster, J. K., Carruthers, M. E., Verdile, G., Sohrabi, H. R., et al. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666151110125704 · Cited by 72
Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias
Rabins, P. V., Rovner, B. W., Rummans, T. A., Schneider, L. S. S., & Tariot, P. N. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.15106 · Cited by 77
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 75
Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease
Boccardi, V., Baroni, M., Mangialasche, F., & Mecocci, P. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.08.002 · Cited by 73
Rate of Lipid Peroxyl Radical Production during Cellular Homeostasis Unraveled via Fluorescence Imaging
Greene, L. E., Lincoln, R., & Cosa, G. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08036 · Cited by 71
Neuroferroptosis in health and diseases
Lei, P., Walker, T. L., & Ayton, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00930-5 · Cited by 77
Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment
Mohan, S., Alhazmi, H. A., Hassani, R., Khuwaja, G., Maheshkumar, V. P., Aldahish, A. A., & Chidambaram, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24786 · Cited by 70
Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer's disease
dos Santos, J. R., de Gois, A. M., MendonÃ§a, D. M. F., & Freire, M. A. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00206 · Cited by 67
Vitamins in Alzheimer’s Disease—Review of the Latest Reports
Mielech, A., Puścion‐Jakubik, A., Markiewicz‐Żukowska, R., & Socha, K. (2020) · Nutrients · doi:10.3390/nu12113458 · Cited by 72
Ferroptosis MRI for early detection of anticancer drug–induced acute cardiac/kidney injuries
Zeng, F., Nijiati, S., Liu, Y., Yang, Q., Liu, X., Zhang, Q., Chen, S., Su, A., Xiong, H., Shi, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.add8539 · Cited by 66
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, S., Bhalerao, A., Powers, M., Gonzalez, M., Mancuso, S., & Cucullo, L. (2023) · Cells · doi:10.3390/cells12162019 · Cited by 65
Plasma Antioxidant Status in Patients with Alzheimer’s Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies
Mullan, K., Cardwell, C. R., McGuinness, B., Woodside, J. V., & McKay, G. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170758 · Cited by 64
Amyloid-beta immunotherapy: the hope for Alzheimer disease?
Barrera-Ocampo, A. A., & Lopera, F. J. (2016) · Colombia medica · doi:10.25100/cm.v47i4.2640 · Cited by 64
Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer’s Disease: The TEAM-AD VA Cooperative Study
Chen, P., Guarino, P., Dysken, M. W., Pallaki, M., Asthana, S., Llorente, M. D., Love, S. B., Vertrees, J. E., Schellenberg, G. D., & Sano, M. C. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718783897 · Cited by 65
Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID
Tate, W. P., Walker, M., Peppercorn, K., Blair, A., & Edgar, C. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065124 · Cited by 62
Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases
Xu, L., Li, C., Wan, T., Sun, X., Lin, X., Yan, D., Li, J., & Wei, P. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-01965-4 · Cited by 69
Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study
Liu, G., Zhao, Y., Jin, S., Hu, Y., Wang, T., Tian, R., Han, Z., Xu, D., & Jiang, Q. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.008 · Cited by 62
Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants
Arslan, J., Jamshed, H., & Qureshi, H. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00231 · Cited by 62
Vitamin E in aging persons with Down syndrome
Sano, M. C., Aisen, P. S. S., Andrews, H., Tsai, W., Lai, F., Dalton, A. J., McCallion, P., Zendell, A. L., Mintz, M., Young, J. M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002714 · Cited by 63
Evaluation and Management of the Elderly Patient Presenting with Cognitive Complaints
Hildreth, K. L., & Church, S. D. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.11.006 · Cited by 66
Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases
Sadowska‐Bartosz, I., & Bartosz, G. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0412-8 · Cited by 60
Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions
Willems, S., Gellrich, L., Chaikuad, A., Kluge, S., Werz, O., Heering, J., Knapp, S., Lorkowski, S., Schubert‐Zsilavecz, M., & Merk, D. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.019 · Cited by 62
Dietary interventions in mild cognitive impairment and dementia
Vlachos, G. S., & Scarmeas, N. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/nscarmeas · Cited by 70
Identification of Ferroptosis-Related Genes in Alzheimer’s Disease Based on Bioinformatic Analysis
Wāng, Y., Chen, G., & Shao, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.823741 · Cited by 58
Effects of dietary RRR α-tocopherol vs all-racemic α-tocopherol on health outcomes
Ranard, K. M., & Erdman, J. W. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux067 · Cited by 60
Oxidative stress in obesity and insulin resistance
Panić, A., Stanimirović, J., Sudar-Milovanovic, E. M., & Isenović, E. R. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00074 · Cited by 63
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 59
Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Liu, G., Weinger, J. G., Lu, Z., Xue, F., & Sadeghpour, S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150538 · Cited by 60
The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial
Tamtaji, O. R., Taghizadeh, M., Aghadavod, E., Mafi, A., Dadgostar, E., Kakhaki, R. D., Abolhassani, J., & Asemi, Z. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.12.006 · Cited by 56
The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Lai, X., Wen, H., Li, Y., Lu, L., & Tang, C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00121 · Cited by 55
Can Nutrients and Dietary Supplements Potentially Improve Cognitive Performance Also in Esports?
Szot, M., Karpęcka-Gałka, E., Dróżdź, R., & Frączek, B. (2022) · Healthcare · doi:10.3390/healthcare10020186 · Cited by 59
Chronic vitamin E deficiency impairs cognitive function in adult zebrafish via dysregulation of brain lipids and energy metabolism
McDougall, M. Q., Choi, J., Magnusson, K. R., Truong, L., Tanguay, R. L., & Traber, M. G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.002 · Cited by 54
Lipophilic antioxidants in neurodegenerative diseases
Chang, K., Cheng, M., Chiang, M.-C., & Chen, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.031 · Cited by 59
From in planta Function to Vitamin-Rich Food Crops: The ACE of Biofortification
Strobbe, S., Lepeleire, J. D., & Straeten, D. V. D. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01862 · Cited by 54
Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia
Yang, T., & Zhang, F. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314804 · Cited by 52
Chemical composition, antioxidant potential, macromolecule damage and neuroprotective activity of Convolvulus pluricaulis
Rachitha, P., Krupashree, K., Jayashree, G. V., Kandikattu, H. K., Amruta, N., Gopalan, N., Rao, M. K., & Khanum, F. (2018) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.11.002 · Cited by 53
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.
Zhou, X., Li, Y., Shi, X., & Ma, C. (2016) · PubMed · Cited by 56
Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers
Hagerman, R. J. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000119 · Cited by 53
Alzheimer's disease: Only prevention makes sense
Viña, J., & Sanz‐Ros, J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13005 · Cited by 55
Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?
George, E., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190232 · Cited by 55
Mechanistic Insight into Antimicrobial and Antioxidant Potential of Jasminum Species: A Herbal Approach for Disease Management
Balkrishna, A., Rohela, A., Kumar, A., Kumar, A., Arya, V., Thakur, P., Olekšák, P., Krejcar, O., Verma, R., Kumar, D., et al. (2021) · Plants · doi:10.3390/plants10061089 · Cited by 60
Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer’s disease therapy
Li, Y., Peng, P., Tang, L., Hu, Y., Hu, Y., & Sheng, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.009 · Cited by 53
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Andrade, S., Nunes, D., Dabur, M., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010212 · Cited by 55
Ferroptosis-mediated immune responses in cancer
Qi, D., & Peng, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188365 · Cited by 53
Nutraceuticals: A Novel Concept in Prevention and Treatment of Alzheimer's Disease and Related Disorders
Farias, G. A., Guzmán‐Martínez, L., Delgado, C., & Maccioni, R. B. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132741 · Cited by 52
Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
Blanco-Silvente, L., Capellà, D., Garre‐Olmo, J., Franch, J. V., & Cervelló, X. C. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0857-5 · Cited by 58
Critical Roles of the Cysteine–Glutathione Axis in the Production of γ-Glutamyl Peptides in the Nervous System
Fujii, J., Osaki, T., Soma, Y., & Matsuda, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098044 · Cited by 56
Oxidative stress and antioxidant therapeutic mechanisms
Liu, H. F., Jiao, Y., Wang, P., Chen, Y., Xu, M., Zhang, X., Zheng, X., & Yang, Z. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108962 · Cited by 61
Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model
Green, C., & Zhang, S. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.011 · Cited by 53
The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained
Joshi, A. U., Kornfeld, O. S., & Mochly‐Rosen, D. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.04.010 · Cited by 55
Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice
Ibrahim, N. F., Yanagisawa, D., Durani, L. W., Hamezah, H. S., Damanhuri, H. A., Ngah, W. Z. W., Tsuji, M., Kiuchi, Y., Ono, K., & Tooyama, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160685 · Cited by 52
Nutrition and Dementia: a review of available research.
Guerchet, M., Albanese, E., Prina, M. A., Prince, M. J., Siervo, M., & Acosta, D. M. (2014) · HAL · Cited by 51
Alzheimer Disease
McDade, E. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001131 · Cited by 56
Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1
Deng, P.-X., Silva, M., Yang, N., Wang, Q., Meng, X., Ye, K., Gao, H., & Zheng, W. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01378-6 · Cited by 53
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
Wischik, C. M., Bentham, P., Gauthier, S., Miller, S., Kook, K., & Schelter, B. O. (2022) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2022.63 · Cited by 55
Nootropics, Functional Foods, and Dietary Patterns for Prevention of Cognitive Decline
Bonetti, F., Brombo, G., & Zuliani, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805376-8.00019-8 · Cited by 52
The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis
Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 51
Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases
Zhao, J., Guo, F., Hou, L., Zhao, Y., & Sun, P. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.068 · Cited by 48
The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population
Lin, Q., Cao, Y., & Gao, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00163 · Cited by 47
Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity
Wang, K., Sun, W., Zhang, L., Guo, W., Xu, J., Liu, S., Zhou, Z., & Zhang, Y. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180525113109 · Cited by 47
Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease
Shah, H., Dehghani, F., Ramezan, M., Gannaban, R. B., Haque, Z. F., Rahimi, F. C., Abbasi, S., & Shin, A. C. (2023) · Antioxidants · doi:10.3390/antiox12020415 · Cited by 48
Ferulic Acid Reverses the Cognitive Dysfunction Caused by Amyloid β Peptide 1-40 Through Anti-Oxidant Activity and Cholinergic Activation in Rats
Tsai, F., Wu, L., Yang, S.-E., Cheng, H., Tsai, C., Wu, C., & Lin, L.-W. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500214 · Cited by 46
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
Yang, W., Zhou, K., Zhou, Y., An, Y., Hu, T., Lu, J. N., Huang, S., & Pei, G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00169 · Cited by 47
RETRACTED ARTICLE: Potential innovation against Alzheimer’s disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery
Karthika, C., Appu, A. P., Akter, R., Rahman, M. H., Tagde, P., Ashraf, G. M., Abdel‐Daim, M. M., Hassan, S. S. U., Abid, A., & BUNGAU, S. G. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17830-7 · Cited by 46
Retracted
Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD
Bao, J., Mahaman, Y. A. R., Liu, R., Wang, J., Zhang, Z., Zhang, B., & Wang, X. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00347 · Cited by 47
The promising role of natural products in Alzheimer's disease
da Rosa, M. M., de Amorim, L. C., Alves, J. V. D. O., Aguiar, I. F. D. S., Oliveira, F. G. D. S., da Silva, M. V., & dos Santos, M. T. C. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100049 · Cited by 53
Pharmacological interventions for cognitive decline in people with Down syndrome
Livingstone, N., Hanratty, J., McShane, R. H., & Macdonald, G. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011546.pub2 · Cited by 44
Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders
Smith, E. S., Porterfield, J. E., & Kannan, R. M. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.009 · Cited by 45
Prolonged Treatment with Centella asiatica Improves Memory, Reduces Amyloid-β Pathology, and Activates NRF2-Regulated Antioxidant Response Pathway in 5xFAD Mice
Zweig, J. A., Brandes, M. S., Brumbach, B. H., Caruso, M. A., Wright, K. M., Quinn, J. F., Soumyanath, A., & Gray, N. E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210271 · Cited by 44
Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer’s Disease: Regulation of Nrf2 by Different Signaling Pathways
Kaur, K., Narang, R. K., & Singh, S. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230726145447 · Cited by 43
Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of Caenorhabditis elegans
Prasansuklab, A., Meemon, K., Sobhon, P., & Tencomnao, T. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2050-3 · Cited by 42
Reuniting overnutrition and undernutrition, macronutrients, and micronutrients
Kim, M., Basharat, A., Santosh, R., Mehdi, S. F., Razvi, Z., Yoo, S. K., Lowell, B., Kumar, A., Brima, W., Danoff, A., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3072 · Cited by 48
Can Polyphenols Inhibit Ferroptosis?
Lesjak, M. M., Simin, N. Đ., & Srai, S. K. (2022) · Antioxidants · doi:10.3390/antiox11010150 · Cited by 44
Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer’s and Parkinson’s Disease and the Efficacy of Antioxidant Treatment
Gogna, T., Housden, B. E., & Houldsworth, A. (2024) · Antioxidants · doi:10.3390/antiox13091138 · Cited by 47
LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice
Wang, J., Lei, X., Cheng, X., Zhang, X., Liu, G., Cheng, J., Xu, Y., Ju, Z., Zhou, W., & Zhang, Y. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0226-6 · Cited by 41
Effects of cognition, function, and behavioral and psychological symptoms on out‐of‐pocket medical and nursing home expenditures and time spent caregiving for persons with dementia
Jutkowitz, E., Kuntz, K. M., Dowd, B. E., Gaugler, J. E., MacLehose, R. F., & Kane, R. L. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.011 · Cited by 42
Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis
Ellis, B., Hye, A., & Snowden, S. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141899 · Cited by 39
Mitochondrial Agents for Bipolar Disorder
Pereira, C. L., Chavarria, V., Vian, J., Ashton, M. M., Berk, M., Marx, W., & Dean, O. M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy018 · Cited by 41
RETRACTED: Nicotinamide Ameliorates Amyloid Beta-Induced Oxidative Stress-Mediated Neuroinflammation and Neurodegeneration in Adult Mouse Brain
Rehman, I., Ahmad, R., Khan, I., Lee, H. J., Park, J., Ullah, R., Choi, M. J., Kang, H. Y., & Kim, M. O. (2021) · Biomedicines · doi:10.3390/biomedicines9040408 · Cited by 47
Retracted
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 51
Recovery of Cognitive Dysfunction via Orally Administered Redox-Polymer Nanotherapeutics in SAMP8 Mice
Chonpathompikunlert, P., Yoshitomi, T., Vong, L. B., Imaizumi, N., Ozaki, Y., & Nagasaki, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126013 · Cited by 41
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40
The role of nutrition in space exploration: Implications for sensorimotor, cognition, behavior and the cerebral changes due to the exposure to radiation, altered gravity, and isolation/confinement hazards of spaceflight
Zwart, S. R., Mulavara, A. P., Williams, T. J., George, K. A., & Smith, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.026 · Cited by 45
Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease
Mani, S., Dubey, R., Lai, I., Babu, M. A., Tyagi, S., Swargiary, G., Mody, D., Singh, M., Agarwal, S., Iqbal, D., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220700 · Cited by 43
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review
Plemel, J. R., Juźwik, C. A., Benson, C. A., Monks, M. R., Harris, C. A., & Ploughman, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515601513 · Cited by 39
Recent advances from metabolomics and lipidomics application in alzheimer’s disease inspiring drug discovery
Čuperlović‐Culf, M., & Badhwar, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1674808 · Cited by 40
Vitamin E: necessary nutrient for neural development and cognitive function
Traber, M. G. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121000914 · Cited by 41

Authors: Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., Prieto, S., Chen, P., Loreck, D. J., Trapp, G., Bakshi, R. S., Mintzer, J. E., Heidebrink, J. L., Vidal-Cardona, A., Arroyo, L. M., Cruz, A. R., Zachariah, S., Kowall, N. W., Chopra, M. P., Craft, S., Thielke, S., Turvey, C. L., Woodman, C., Monnell, K. A., Gordon, K., Tomaska, J., Segal, Y., Peduzzi, P. N., & Guarino, P. D.
Affiliations: Minneapolis VA Health Care System (US)
James J. Peters VA Medical Center (US)
William S. Middleton Memorial Veterans Hospital (US)
Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico
Louis Stokes Cleveland VA Medical Center (US)
Washington DC VA Medical Center (US)
University of Pennsylvania (US)
Miami VA Healthcare System (US)
VA Maryland Health Care System (US)
VA North Texas Health Care System (US)
Medical University of South Carolina (US)
VA Ann Arbor Healthcare System (US)
VA Caribbean Healthcare System, San Juan, Puerto Rico
VA Caribbean Healthcare System (PR)
Bay Pines VA Healthcare System (US)
VA Boston Healthcare System (US)
University of Washington (US)
University of Iowa (US)
W. G. (Bill) Hefner VA Medical Center (US)
Yale University (US)
ORCID: Sano, Mary
Asthana, Sanjay
Vertrees, Julia E.
Schellenberg, Gerard D.
McCarten, J. Riley
Chen, Peijun
Mintzer, Jacobo E.
Heidebrink, Judith L.
Kowall, Neil W.
Craft, Suzanne
Thielke, Stephen
Turvey, Carolyn L.
Woodman, Catherine
Tomaska, Julie
Peduzzi, Peter N.
Guarino, Peter D.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2014-01-01
Volume: 311
Issue: 1
Pages: 33
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2013.282834
PMC: PMC4109898
OpenAlex: W2128047032
Cited by: 628
References: 40
Citations by year: 2026: 34 · 2025: 41 · 2024: 36 · 2023: 54 · 2022: 56 · 2021: 53 · 2020: 47 · 2019: 47 · 2018: 61 · 2017: 48 · 2016: 50 · 2015: 55 · 2014: 44
FWCI: 35.66
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (P50AG005138, P30AG013846, P50AG005136)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: Alzheimer's disease, vitamin E, alpha-tocopherol, memantine, functional decline, activities of daily living, acetylcholinesterase inhibitors, disease progression, caregiver burden, neuropsychiatric symptoms, adverse events, infections and infestations, combination therapy, veterans, older adults, cognitive decline, mortality, quality of life, cost-effectiveness
MeSH terms: Activities of Daily Living, Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Cholinesterase Inhibitors, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memantine, Middle Aged, Severity of Illness Index, Vitamin E, Dopamine Agents, Treatment Outcome, Caregivers, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks